Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines, No. 009, October 2004
(2004; 6 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoWhy pharmacovigilance is needed
Ver el documentoThe aims of pharmacovigilance
Abrir esta carpeta y ver su contenidoPartners in pharmacovigilance
Ver el documentoCommunicating the outcome of pharmacovigilance
Ver el documentoWHO Programme for International Drug Monitoring
Ver el documentoConclusion
Ver el documentoKey documents
 

Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines, No. 009, October 2004

October 2004
World Health Organization Geneva

Modern medicines have changed the way in which diseases are managed and controlled. However, despite all their benefits, evidence continues to mount that adverse reactions to medicines are a common, yet often preventable, cause of illness, disability and even death. In some countries, adverse drug reactions (ADRs) rank among the top 10 leading causes of mortality. Aside from the intrinsic dangers associated with the products them-selves, individual patients may exhibit particular and unpredictable sensitivities to certain medicines. In addition, if more than one medicine is prescribed, there is always a risk of negative interactions. The selection and use of the best and safest medicine(s) for a given individual out of the many choices avail-able thus requires considerable skill on behalf of the prescribing practitioner.

In order to prevent or reduce harm to patients and thus improve public health, mechanisms for evaluating and monitoring the safety of medicines in clinical use are vital. In practice this means having in place a well-organized pharmacovigilance system. Pharmacovigilance - an umbrella term used to describe the processes for monitoring and evaluating ADRs - is a key component of effective drug regulation systems, clinical practice and public health programmes.

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019